Business

Implications of Phase 3 Trial Results Assessing Efficacy, Safety of Dapagliflozin in Patients With Type 2 Diabetes Hospitalized With COVID-19

Mikhail Kosiborod, MD, heart specialist and vice chairman of analysis at Saint Luke’s Well being in Kansas Metropolis, mentioned the implications of the DARE-19 trial outcomes assessing dapagliflozin as a remedy for sufferers with sort 2 diabetes hospitalized with COVID-19.

Pharmacy Occasions interviewed Mikhail Kosiborod, MD, heart specialist and vice chairman of analysis at Saint Luke’s Well being in Kansas Metropolis, on the outcomes from the DARE-19 trial assessing the efficacy and security of dapagliflozin in sufferers with and with out sort 2 diabetes hospitalized with COVID-19.

Throughout the dialogue, Kosiborod defined the implications of the trial outcomes on the remedy alternatives accessible for this affected person inhabitants.

https://www.pharmacytimes.com/view/implications-of-phase-3-trial-results-assessing-efficacy-safety-of-dapagliflozin-in-patients-with-type-2-diabetes-hospitalized-with-covid-19

Apkdownload

Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@interreviewed.com. The content will be deleted within 24 hours.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

ten + nineteen =

Back to top button